• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS2500462 糠酸氟替卡松鼻用喷雾剂 fluticasone furoate Spray Chemical Drugs(4) Generic Drug 2025-01-24 QILU Pharmaceutical Co Ltd view
JXHS2400116 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Import Drug Application 2024-12-21 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline Intellectual Property Development Ltd view
JXHS2400115 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Import Drug Application 2024-12-21 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline Intellectual Property Development Ltd view
JTH2400165 糠酸氟替卡松 fluticasone furoate Active ingredient Chemical Drugs Disposable Import Drug Application 2024-09-26 STERLING SpA;Benova(Tianjin)Innovation Pharmaceutical Research Co Ltd view
JYHB2400459 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2024-08-20 Glaxo Operations UK Ltd;GlaxoSmithKline Intellectual Property Development Ltd view
JTH2400065 糠酸氟替卡松标准品 Other Chemical Drugs Disposable Import Drug Application 2024-05-09 GlaxoSmithKline (China) Investment Co Ltd;LGC Standards Canada Ltd view
JYHZ2400073 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) License Renew 2024-03-26 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd view
JTH2400035 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs Disposable Import Drug Application 2024-03-04 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd view
JYHB2400111 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2024-03-02 Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd view
JYHB2300730 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2023-12-19 Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd view
JYHB2300304 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2023-05-24 Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd view
JYHZ2300033 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) fluticasone furoate;vilanterol Powder for inhalation Chemical Drugs(5.1) License Renew 2023-01-18 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd view
JYHZ2300034 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅲ) fluticasone furoate;vilanterol Powder for inhalation Chemical Drugs(5.1) License Renew 2023-01-18 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd view
JYHB2200313 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2022-06-21 Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd view
JTH2200072 糠酸氟替卡松 fluticasone furoate Active ingredient Chemical Drugs Disposable Import Drug Application 2022-04-06 Aarti Industries Ltd;QILU Pharmaceutical Co Ltd view
JYHB2101625 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) fluticasone furoate;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2021-12-30 Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd view
JYHB2101626 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅲ) fluticasone furoate;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2021-12-30 Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd view
JYHZ2100573 糠酸氟替卡松鼻用喷雾剂 fluticasone furoate Spray Chemical Drugs License Renew 2021-07-08 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd view
JYHB2100113 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅲ) fluticasone furoate;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2021-02-03 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd In Review 2021-02-03 view
JYHB2100112 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) fluticasone furoate;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2021-02-03 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd In Review 2021-02-03 view